Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dinan

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
JAMA Network Open|April 15, 2025
Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast CancerSida Huang, Sarah J Westvold, Pamela R Soulos, et al.
JCO Oncology Practice|January 3, 2023
Clinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer TreatmentDevon K Check, Katie F Jones, Laura J Fish, et al.
Clinical Genitourinary Cancer|April 5, 2025
Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell CarcinomaHannah D McManus, Jessica B Long, Sarah J Westvold, et al.
Health Services Research|July 17, 2025
Machine Learning Risk Stratification for Older Breast Cancer Survivors: Clinical Care ImplicationsStephanie B Wheeler, Jason Rotter, Lisa P Spees, et al.
Journal of Geriatric Oncology|January 8, 2022
Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinomaSamuel M Miller, Lauren E Wilson, Melissa A Greiner, et al.
JNCI Cancer Spectrum|May 18, 2023
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinomaRyan D Chow, Jessica B Long, Sirad Hassan, et al.
Kidney Cancer (Clifton, Va.)|October 11, 2021
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United StatesLauren E Wilson, Lisa Spees, Jessica Pritchard, et al.
Breast Cancer Research and Treatment|October 24, 2023
Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancerDevon K Check, Bradford E Jackson, Katherine E Reeder-Hayes, et al.
JAMA Network Open|April 30, 2024
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell CarcinomaSyed N Rahman, Jessica B Long, Sarah J Westvold, et al.
Journal of the National Cancer Institute|September 19, 2025
Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor studyMichaela A Dinan, Kayla L Stratton, Wendy M Leisenring, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
JAMA Network Open|April 15, 2025
Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast CancerSida Huang, Sarah J Westvold, Pamela R Soulos, et al.
JCO Oncology Practice|January 3, 2023
Clinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer TreatmentDevon K Check, Katie F Jones, Laura J Fish, et al.
Clinical Genitourinary Cancer|April 5, 2025
Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell CarcinomaHannah D McManus, Jessica B Long, Sarah J Westvold, et al.
Health Services Research|July 17, 2025
Machine Learning Risk Stratification for Older Breast Cancer Survivors: Clinical Care ImplicationsStephanie B Wheeler, Jason Rotter, Lisa P Spees, et al.
Journal of Geriatric Oncology|January 8, 2022
Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinomaSamuel M Miller, Lauren E Wilson, Melissa A Greiner, et al.
JNCI Cancer Spectrum|May 18, 2023
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinomaRyan D Chow, Jessica B Long, Sirad Hassan, et al.
Kidney Cancer (Clifton, Va.)|October 11, 2021
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United StatesLauren E Wilson, Lisa Spees, Jessica Pritchard, et al.
Breast Cancer Research and Treatment|October 24, 2023
Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancerDevon K Check, Bradford E Jackson, Katherine E Reeder-Hayes, et al.
JAMA Network Open|April 30, 2024
Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell CarcinomaSyed N Rahman, Jessica B Long, Sarah J Westvold, et al.
Journal of the National Cancer Institute|September 19, 2025
Treatment exposure-based risk-stratification for care of survivors of childhood cancer: a report from the childhood cancer survivor studyMichaela A Dinan, Kayla L Stratton, Wendy M Leisenring, et al.
Pageof 12